Where it may be relevant
- Eligible travellers needing pre-exposure rabies protection
- Groups where a licensed intradermal product and trained clinician are available
- Travellers whose immune status and medicines do not make the shortened course unsuitable
Dose schedules.
The clinician will select the appropriate licensed schedule after reviewing age, health, previous doses and departure date.
Licensed intradermal course
Eligible immunocompetent travellers
Two-site administration may be required at each visit according to the selected product.
Who may be eligible
- People suitable for the selected product's licensed intradermal schedule
- Travellers assessed by a clinician experienced in the technique
Who may not be eligible
- Anyone with a confirmed severe allergic reaction to a previous dose or a vaccine ingredient
- People who are acutely unwell with a significant fever may need vaccination deferred
- Pregnancy, breastfeeding, immune suppression and current medicines must be reviewed individually
- A shortened intradermal schedule is unsuitable for some immunocompromised travellers
- Not every rabies vaccine is licensed for intradermal administration in the UK
Potential side effects
- Pain, redness or swelling where the injection is given
- Headache, tiredness, muscle aches or a mild fever
- Feeling faint around the time of vaccination
Important risks and precautions
- A severe allergic reaction is very rare and requires urgent treatment
- Protection is not absolute, so relevant food, water, bite or exposure precautions remain important
- The exact product and schedule must be confirmed during a clinical assessment
- Incorrect intradermal technique may produce an unreliable response
- Urgent post-exposure treatment remains essential after every potential exposure
Clinical references
Further information.
Information is general and does not replace a personal assessment, prescribing decision or the latest destination-specific advice.
